Global Transcatheter Heart Valve Replacement and Repair Market
Global Transcatheter Heart Valve Replacement and Repair Market

Transcatheter Heart Valve Replacement and Repair Comprehensive Study by Type (Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Repair and Replacement, Transcatheter Pulmonary Valve Replacement), Disease Type (Aortic Valvular Heart Disease, Mitral Valvular Heart Disease, Pulmonary Valvular Heart Disease), End Use (Hospitals, Cardiac Catheterization Laboratory, Surgical Ambulatory Services) Players and Region - Global Market Outlook to 2026

Transcatheter Heart Valve Replacement and Repair Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Aug 2021 Edition 219 Pages 212 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Transcatheter Heart Valve Replacement and Repair?
Transcatheter heart valve replacement is a minimally invasive technique that replaces a constricted or failing aortic valve (aortic valve stenosis). Transcatheter heart valve implantation is another name for transcatheter heart valve replacement. For those who are at intermediate or high risk of problems from surgical aortic valve replacement (open-heart surgery), TAVR may be advisable treatment. Growing number of heart related chronic diseases as well as increasing geriatrics population are significant reasons for the growth of the transcatheter heart valve replacement and repair market. High costs or lack of skilled professionals in certain regions may be limiting factor for the growth of the market. Currently, the North American region is the leading market.

The market study is broken down by Type (Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Repair and Replacement and Transcatheter Pulmonary Valve Replacement) and major geographies with country level break-up.

Changing urban lifestyle and drastic changes in the environment has led to growing number of heart related chronic diseases. Similarly, the growing number of geriatrics population too has been significant towards exponential rise of transcatheter heart valve replacement and repair market. Medical insurance and government subsidies can be primary towards providing comprehensive treatment to every required person. North America is the leading market of transcatheter heart valve replacement and repair market. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abbott Laboratories (United States), Boston Scientific Corporation (United States), Medtronic Plc (Ireland), Braile Biomedica (Brazil), St. Jude Medical, Inc. (United States), Edwards Lifesciences (United States), CryoLife, Inc. (United States), Neovasc Inc. (Canada), JenaValve Technology (United States) and LivaNova, Plc (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are HeartWare International Inc. (United States), MiCardia Corporation (United States) and HighLife Medical (France).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Transcatheter Heart Valve Replacement and Repair market by Type, Application and Region.

On the basis of geography, the market of Transcatheter Heart Valve Replacement and Repair has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Disease Type, the sub-segment i.e. Aortic Valvular Heart Disease will boost the Transcatheter Heart Valve Replacement and Repair market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End Use, the sub-segment i.e. Hospitals will boost the Transcatheter Heart Valve Replacement and Repair market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
In 2019, Venus Medtech (Hangzhou) Inc., a China based leading transcatheter heart valve medical device manufacturer and seller has announced acquisition of Keystone Heart Ltd., which is an Israel based medical device company specialised in the production of Cerebral Embolic Protection Devices such as TriGUARD 3. The acquisition deal would enable Venus Medtech to lower the danger of brain injury during cardiac surgeries, but also build a foothold in the US and EMEA, allowing us to present our whole product line.
In 2020, Medtronic plc, an American-Irish registered medical device company has announced a partnership with The Foundry, a medical device company incubator. The partnership would be aimed at combining Medtronic's expertise in Structural Heart with The Foundry's innovations in transcatheter mitral valve repair and replacement.


Market Trend
  • Transcatheter Mitral Valve Repair and Replacement Accounts for Largest Market Share

Market Drivers
  • Rising Number of Chronic Diseases Related to Heart
  • Increase in Geriatrics Population

Opportunities
  • Asia Pacific Market is expected to Present Huge Opportunity to Expand due to Presence of Emerging Economies in the Region

Restraints
  • High Cost of the Treatment

Challenges
  • Lack of Skilled Medical Professionals or Required Medical Infrastructure in Developing Countries


Key Target Audience
Transcatheter Heart Valve Replacement and Repair Providers, New Entrants/Investors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industries

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Frequently Asked Questions (FAQ):

1. What all players are profiled in the study?
The standard version of the report profiles players such as Abbott Laboratories (United States), Boston Scientific Corporation (United States), Medtronic Plc (Ireland), Braile Biomedica (Brazil), St. Jude Medical, Inc. (United States), Edwards Lifesciences (United States), CryoLife, Inc. (United States), Neovasc Inc. (Canada), JenaValve Technology (United States) and LivaNova, Plc (United Kingdom) etc.

2. Can we have customized study for Transcatheter Heart Valve Replacement and Repair Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

3. What would be the Market Size of Transcatheter Heart Valve Replacement and Repair Market by 2026?
Analysts at AMA estimates Transcatheter Heart Valve Replacement and Repair Market to reach USD Million by 2026.
Report Objectives / Segmentation Covered
By Type
  • Transcatheter Aortic Valve Replacement
  • Transcatheter Mitral Valve Repair and Replacement
  • Transcatheter Pulmonary Valve Replacement
By Disease Type
  • Aortic Valvular Heart Disease
  • Mitral Valvular Heart Disease
  • Pulmonary Valvular Heart Disease

By End Use
  • Hospitals
  • Cardiac Catheterization Laboratory
  • Surgical Ambulatory Services

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Number of Chronic Diseases Related to Heart
      • 3.2.2. Increase in Geriatrics Population
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Medical Professionals or Required Medical Infrastructure in Developing Countries
    • 3.4. Market Trends
      • 3.4.1. Transcatheter Mitral Valve Repair and Replacement Accounts for Largest Market Share
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Transcatheter Heart Valve Replacement and Repair, by Type, Disease Type, End Use and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Transcatheter Heart Valve Replacement and Repair (Value)
      • 5.2.1. Global Transcatheter Heart Valve Replacement and Repair by: Type (Value)
        • 5.2.1.1. Transcatheter Aortic Valve Replacement
        • 5.2.1.2. Transcatheter Mitral Valve Repair and Replacement
        • 5.2.1.3. Transcatheter Pulmonary Valve Replacement
      • 5.2.2. Global Transcatheter Heart Valve Replacement and Repair by: Disease Type (Value)
        • 5.2.2.1. Aortic Valvular Heart Disease
        • 5.2.2.2. Mitral Valvular Heart Disease
        • 5.2.2.3. Pulmonary Valvular Heart Disease
      • 5.2.3. Global Transcatheter Heart Valve Replacement and Repair by: End Use (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Cardiac Catheterization Laboratory
        • 5.2.3.3. Surgical Ambulatory Services
      • 5.2.4. Global Transcatheter Heart Valve Replacement and Repair Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Transcatheter Heart Valve Replacement and Repair: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic Plc (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Braile Biomedica (Brazil)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. St. Jude Medical, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Edwards Lifesciences (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. CryoLife, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Neovasc Inc. (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. JenaValve Technology (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. LivaNova, Plc (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Transcatheter Heart Valve Replacement and Repair Sale, by Type, Disease Type, End Use and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Transcatheter Heart Valve Replacement and Repair (Value)
      • 7.2.1. Global Transcatheter Heart Valve Replacement and Repair by: Type (Value)
        • 7.2.1.1. Transcatheter Aortic Valve Replacement
        • 7.2.1.2. Transcatheter Mitral Valve Repair and Replacement
        • 7.2.1.3. Transcatheter Pulmonary Valve Replacement
      • 7.2.2. Global Transcatheter Heart Valve Replacement and Repair by: Disease Type (Value)
        • 7.2.2.1. Aortic Valvular Heart Disease
        • 7.2.2.2. Mitral Valvular Heart Disease
        • 7.2.2.3. Pulmonary Valvular Heart Disease
      • 7.2.3. Global Transcatheter Heart Valve Replacement and Repair by: End Use (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Cardiac Catheterization Laboratory
        • 7.2.3.3. Surgical Ambulatory Services
      • 7.2.4. Global Transcatheter Heart Valve Replacement and Repair Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Transcatheter Heart Valve Replacement and Repair: by Type(USD Million)
  • Table 2. Transcatheter Heart Valve Replacement and Repair Transcatheter Aortic Valve Replacement , by Region USD Million (2015-2020)
  • Table 3. Transcatheter Heart Valve Replacement and Repair Transcatheter Mitral Valve Repair and Replacement , by Region USD Million (2015-2020)
  • Table 4. Transcatheter Heart Valve Replacement and Repair Transcatheter Pulmonary Valve Replacement , by Region USD Million (2015-2020)
  • Table 5. Transcatheter Heart Valve Replacement and Repair: by Disease Type(USD Million)
  • Table 6. Transcatheter Heart Valve Replacement and Repair Aortic Valvular Heart Disease , by Region USD Million (2015-2020)
  • Table 7. Transcatheter Heart Valve Replacement and Repair Mitral Valvular Heart Disease , by Region USD Million (2015-2020)
  • Table 8. Transcatheter Heart Valve Replacement and Repair Pulmonary Valvular Heart Disease , by Region USD Million (2015-2020)
  • Table 9. Transcatheter Heart Valve Replacement and Repair: by End Use(USD Million)
  • Table 10. Transcatheter Heart Valve Replacement and Repair Hospitals , by Region USD Million (2015-2020)
  • Table 11. Transcatheter Heart Valve Replacement and Repair Cardiac Catheterization Laboratory , by Region USD Million (2015-2020)
  • Table 12. Transcatheter Heart Valve Replacement and Repair Surgical Ambulatory Services , by Region USD Million (2015-2020)
  • Table 13. South America Transcatheter Heart Valve Replacement and Repair, by Country USD Million (2015-2020)
  • Table 14. South America Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 15. South America Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 16. South America Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 17. Brazil Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 18. Brazil Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 19. Brazil Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 20. Argentina Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 21. Argentina Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 22. Argentina Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 23. Rest of South America Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 24. Rest of South America Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 25. Rest of South America Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 26. Asia Pacific Transcatheter Heart Valve Replacement and Repair, by Country USD Million (2015-2020)
  • Table 27. Asia Pacific Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 28. Asia Pacific Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 29. Asia Pacific Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 30. China Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 31. China Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 32. China Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 33. Japan Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 34. Japan Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 35. Japan Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 36. India Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 37. India Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 38. India Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 39. South Korea Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 40. South Korea Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 41. South Korea Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 42. Taiwan Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 43. Taiwan Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 44. Taiwan Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 45. Australia Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 46. Australia Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 47. Australia Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 51. Europe Transcatheter Heart Valve Replacement and Repair, by Country USD Million (2015-2020)
  • Table 52. Europe Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 53. Europe Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 54. Europe Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 55. Germany Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 56. Germany Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 57. Germany Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 58. France Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 59. France Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 60. France Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 61. Italy Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 62. Italy Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 63. Italy Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 64. United Kingdom Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 65. United Kingdom Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 66. United Kingdom Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 67. Netherlands Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 68. Netherlands Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 69. Netherlands Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 70. Rest of Europe Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 71. Rest of Europe Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 72. Rest of Europe Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 73. MEA Transcatheter Heart Valve Replacement and Repair, by Country USD Million (2015-2020)
  • Table 74. MEA Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 75. MEA Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 76. MEA Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 77. Middle East Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 78. Middle East Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 79. Middle East Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 80. Africa Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 81. Africa Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 82. Africa Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 83. North America Transcatheter Heart Valve Replacement and Repair, by Country USD Million (2015-2020)
  • Table 84. North America Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 85. North America Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 86. North America Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 87. United States Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 88. United States Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 89. United States Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 90. Canada Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 91. Canada Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 92. Canada Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 93. Mexico Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2015-2020)
  • Table 94. Mexico Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2015-2020)
  • Table 95. Mexico Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2015-2020)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Transcatheter Heart Valve Replacement and Repair: by Type(USD Million)
  • Table 107. Transcatheter Heart Valve Replacement and Repair Transcatheter Aortic Valve Replacement , by Region USD Million (2021-2026)
  • Table 108. Transcatheter Heart Valve Replacement and Repair Transcatheter Mitral Valve Repair and Replacement , by Region USD Million (2021-2026)
  • Table 109. Transcatheter Heart Valve Replacement and Repair Transcatheter Pulmonary Valve Replacement , by Region USD Million (2021-2026)
  • Table 110. Transcatheter Heart Valve Replacement and Repair: by Disease Type(USD Million)
  • Table 111. Transcatheter Heart Valve Replacement and Repair Aortic Valvular Heart Disease , by Region USD Million (2021-2026)
  • Table 112. Transcatheter Heart Valve Replacement and Repair Mitral Valvular Heart Disease , by Region USD Million (2021-2026)
  • Table 113. Transcatheter Heart Valve Replacement and Repair Pulmonary Valvular Heart Disease , by Region USD Million (2021-2026)
  • Table 114. Transcatheter Heart Valve Replacement and Repair: by End Use(USD Million)
  • Table 115. Transcatheter Heart Valve Replacement and Repair Hospitals , by Region USD Million (2021-2026)
  • Table 116. Transcatheter Heart Valve Replacement and Repair Cardiac Catheterization Laboratory , by Region USD Million (2021-2026)
  • Table 117. Transcatheter Heart Valve Replacement and Repair Surgical Ambulatory Services , by Region USD Million (2021-2026)
  • Table 118. South America Transcatheter Heart Valve Replacement and Repair, by Country USD Million (2021-2026)
  • Table 119. South America Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 120. South America Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 121. South America Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 122. Brazil Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 123. Brazil Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 124. Brazil Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 125. Argentina Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 126. Argentina Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 127. Argentina Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 128. Rest of South America Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 129. Rest of South America Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 130. Rest of South America Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 131. Asia Pacific Transcatheter Heart Valve Replacement and Repair, by Country USD Million (2021-2026)
  • Table 132. Asia Pacific Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 133. Asia Pacific Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 134. Asia Pacific Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 135. China Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 136. China Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 137. China Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 138. Japan Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 139. Japan Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 140. Japan Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 141. India Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 142. India Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 143. India Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 144. South Korea Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 145. South Korea Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 146. South Korea Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 147. Taiwan Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 148. Taiwan Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 149. Taiwan Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 150. Australia Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 151. Australia Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 152. Australia Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 153. Rest of Asia-Pacific Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 154. Rest of Asia-Pacific Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 155. Rest of Asia-Pacific Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 156. Europe Transcatheter Heart Valve Replacement and Repair, by Country USD Million (2021-2026)
  • Table 157. Europe Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 158. Europe Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 159. Europe Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 160. Germany Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 161. Germany Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 162. Germany Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 163. France Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 164. France Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 165. France Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 166. Italy Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 167. Italy Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 168. Italy Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 169. United Kingdom Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 170. United Kingdom Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 171. United Kingdom Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 172. Netherlands Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 173. Netherlands Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 174. Netherlands Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 175. Rest of Europe Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 176. Rest of Europe Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 177. Rest of Europe Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 178. MEA Transcatheter Heart Valve Replacement and Repair, by Country USD Million (2021-2026)
  • Table 179. MEA Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 180. MEA Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 181. MEA Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 182. Middle East Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 183. Middle East Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 184. Middle East Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 185. Africa Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 186. Africa Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 187. Africa Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 188. North America Transcatheter Heart Valve Replacement and Repair, by Country USD Million (2021-2026)
  • Table 189. North America Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 190. North America Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 191. North America Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 192. United States Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 193. United States Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 194. United States Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 195. Canada Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 196. Canada Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 197. Canada Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 198. Mexico Transcatheter Heart Valve Replacement and Repair, by Type USD Million (2021-2026)
  • Table 199. Mexico Transcatheter Heart Valve Replacement and Repair, by Disease Type USD Million (2021-2026)
  • Table 200. Mexico Transcatheter Heart Valve Replacement and Repair, by End Use USD Million (2021-2026)
  • Table 201. Research Programs/Design for This Report
  • Table 202. Key Data Information from Secondary Sources
  • Table 203. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Transcatheter Heart Valve Replacement and Repair: by Type USD Million (2015-2020)
  • Figure 5. Global Transcatheter Heart Valve Replacement and Repair: by Disease Type USD Million (2015-2020)
  • Figure 6. Global Transcatheter Heart Valve Replacement and Repair: by End Use USD Million (2015-2020)
  • Figure 7. South America Transcatheter Heart Valve Replacement and Repair Share (%), by Country
  • Figure 8. Asia Pacific Transcatheter Heart Valve Replacement and Repair Share (%), by Country
  • Figure 9. Europe Transcatheter Heart Valve Replacement and Repair Share (%), by Country
  • Figure 10. MEA Transcatheter Heart Valve Replacement and Repair Share (%), by Country
  • Figure 11. North America Transcatheter Heart Valve Replacement and Repair Share (%), by Country
  • Figure 12. Global Transcatheter Heart Valve Replacement and Repair share by Players 2020 (%)
  • Figure 13. Global Transcatheter Heart Valve Replacement and Repair share by Players (Top 3) 2020(%)
  • Figure 14. Global Transcatheter Heart Valve Replacement and Repair share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 17. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 18. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. Boston Scientific Corporation (United States) Revenue: by Geography 2020
  • Figure 20. Medtronic Plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 21. Medtronic Plc (Ireland) Revenue: by Geography 2020
  • Figure 22. Braile Biomedica (Brazil) Revenue, Net Income and Gross profit
  • Figure 23. Braile Biomedica (Brazil) Revenue: by Geography 2020
  • Figure 24. St. Jude Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. St. Jude Medical, Inc. (United States) Revenue: by Geography 2020
  • Figure 26. Edwards Lifesciences (United States) Revenue, Net Income and Gross profit
  • Figure 27. Edwards Lifesciences (United States) Revenue: by Geography 2020
  • Figure 28. CryoLife, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. CryoLife, Inc. (United States) Revenue: by Geography 2020
  • Figure 30. Neovasc Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 31. Neovasc Inc. (Canada) Revenue: by Geography 2020
  • Figure 32. JenaValve Technology (United States) Revenue, Net Income and Gross profit
  • Figure 33. JenaValve Technology (United States) Revenue: by Geography 2020
  • Figure 34. LivaNova, Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. LivaNova, Plc (United Kingdom) Revenue: by Geography 2020
  • Figure 36. Global Transcatheter Heart Valve Replacement and Repair: by Type USD Million (2021-2026)
  • Figure 37. Global Transcatheter Heart Valve Replacement and Repair: by Disease Type USD Million (2021-2026)
  • Figure 38. Global Transcatheter Heart Valve Replacement and Repair: by End Use USD Million (2021-2026)
  • Figure 39. South America Transcatheter Heart Valve Replacement and Repair Share (%), by Country
  • Figure 40. Asia Pacific Transcatheter Heart Valve Replacement and Repair Share (%), by Country
  • Figure 41. Europe Transcatheter Heart Valve Replacement and Repair Share (%), by Country
  • Figure 42. MEA Transcatheter Heart Valve Replacement and Repair Share (%), by Country
  • Figure 43. North America Transcatheter Heart Valve Replacement and Repair Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • Boston Scientific Corporation (United States)
  • Medtronic Plc (Ireland)
  • Braile Biomedica (Brazil)
  • St. Jude Medical, Inc. (United States)
  • Edwards Lifesciences (United States)
  • CryoLife, Inc. (United States)
  • Neovasc Inc. (Canada)
  • JenaValve Technology (United States)
  • LivaNova, Plc (United Kingdom)
Additional players considered in the study are as follows:
HeartWare International Inc. (United States) , MiCardia Corporation (United States) , HighLife Medical (France)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation